IS4679A - Bensóþíasólonafleiður - Google Patents

Bensóþíasólonafleiður

Info

Publication number
IS4679A
IS4679A IS4679A IS4679A IS4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A
Authority
IS
Iceland
Prior art keywords
bensóþíasólonafleiður
Prior art date
Application number
IS4679A
Other languages
English (en)
Inventor
Victor Bonnert Roger
Charles Brown Roger
Alan Cage Peter
Ince Francis
Pairaudeau Garry
Original Assignee
Astrazenenca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518952.8A external-priority patent/GB9518952D0/en
Priority claimed from GBGB9614346.6A external-priority patent/GB9614346D0/en
Application filed by Astrazenenca Ab filed Critical Astrazenenca Ab
Publication of IS4679A publication Critical patent/IS4679A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IS4679A 1995-09-15 1998-03-04 Bensóþíasólonafleiður IS4679A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518952.8A GB9518952D0 (en) 1995-09-15 1995-09-15 Compounds
GBGB9614346.6A GB9614346D0 (en) 1996-07-10 1996-07-10 Benzothiazolone derivatives
PCT/GB1996/002247 WO1997010227A1 (en) 1995-09-15 1996-09-12 Benzothiazolone derivatives

Publications (1)

Publication Number Publication Date
IS4679A true IS4679A (is) 1998-03-04

Family

ID=26307771

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4679A IS4679A (is) 1995-09-15 1998-03-04 Bensóþíasólonafleiður

Country Status (29)

Country Link
US (5) US5846989A (is)
EP (1) EP0850232B1 (is)
JP (1) JP3213327B2 (is)
KR (1) KR19990044674A (is)
CN (2) CN1073098C (is)
AR (1) AR004512A1 (is)
AT (1) ATE190610T1 (is)
AU (1) AU706094B2 (is)
BR (1) BR9610316A (is)
CA (1) CA2231003A1 (is)
CY (1) CY2227B1 (is)
CZ (1) CZ74098A3 (is)
DE (1) DE69607183T2 (is)
EE (1) EE03395B1 (is)
ES (1) ES2146901T3 (is)
GR (1) GR3033681T3 (is)
HK (1) HK1008781A1 (is)
HU (1) HUP9802393A3 (is)
IL (4) IL141955A0 (is)
IS (1) IS4679A (is)
MY (1) MY113518A (is)
NO (1) NO310721B1 (is)
NZ (4) NZ318007A (is)
PL (1) PL325517A1 (is)
PT (1) PT850232E (is)
SK (1) SK282394B6 (is)
TR (1) TR199800457T2 (is)
TW (1) TW356468B (is)
WO (1) WO1997010227A1 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020260A2 (en) * 1997-10-17 1999-04-29 Eurogene Limited The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
ES2329586T3 (es) 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
CN101282950B (zh) * 2005-08-09 2012-09-12 阿斯利康(瑞典)有限公司 新颖的苯并噻唑酮衍生物
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
AU2007336074B2 (en) * 2006-12-20 2011-09-22 Astrazeneca Ab Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
RU2011101664A (ru) * 2008-06-20 2012-07-27 Астразенека Аб (Se) Фармацевтическая композиция, содержащая 4-гидрокси-2-оксо-2, 3-дигидро-1, 3-бензотиазол-7-ильное соединение, для модулирования активности бета2- адренорецепторов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
AU4945185A (en) * 1984-11-08 1986-05-15 Syntex (U.S.A.) Inc. Dialkyl aminoethylaniline derivatives
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds

Also Published As

Publication number Publication date
JP3213327B2 (ja) 2001-10-02
IL141955A0 (en) 2002-03-10
NO981104D0 (no) 1998-03-12
AU6937196A (en) 1997-04-01
IL123639A (en) 2002-04-21
HUP9802393A2 (hu) 1999-04-28
DE69607183D1 (de) 2000-04-20
US5977384A (en) 1999-11-02
NZ332397A (en) 1999-02-25
WO1997010227A1 (en) 1997-03-20
MX9801963A (es) 1998-08-30
CN1356323A (zh) 2002-07-03
SK29598A3 (en) 1999-01-11
EP0850232A1 (en) 1998-07-01
EE9800069A (et) 1998-10-15
CY2227B1 (en) 2003-04-18
EE03395B1 (et) 2001-04-16
NZ332395A (en) 1999-02-25
CA2231003A1 (en) 1997-03-20
CN1073098C (zh) 2001-10-17
NZ318007A (en) 1999-07-29
AR004512A1 (es) 1998-12-16
SK282394B6 (sk) 2002-01-07
US6008365A (en) 1999-12-28
CZ74098A3 (cs) 1998-08-12
US5846989A (en) 1998-12-08
TW356468B (en) 1999-04-21
TR199800457T2 (xx) 1998-07-21
HK1008781A1 (en) 1999-05-21
IL141954A0 (en) 2002-03-10
HUP9802393A3 (en) 2000-01-28
US6080869A (en) 2000-06-27
US5973167A (en) 1999-10-26
IL141956A0 (en) 2002-03-10
CN1202163A (zh) 1998-12-16
KR19990044674A (ko) 1999-06-25
BR9610316A (pt) 1999-07-06
EP0850232B1 (en) 2000-03-15
ATE190610T1 (de) 2000-04-15
DE69607183T2 (de) 2000-11-23
NZ332396A (en) 1999-02-25
NO310721B1 (no) 2001-08-20
ES2146901T3 (es) 2000-08-16
NO981104L (no) 1998-05-14
JPH11512422A (ja) 1999-10-26
PL325517A1 (en) 1998-08-03
GR3033681T3 (en) 2000-10-31
MY113518A (en) 2002-03-30
AU706094B2 (en) 1999-06-10
IL123639A0 (en) 1998-10-30
PT850232E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
ATA135896A (de) Skibob
NO981104D0 (no) Benzotiazolonderivater
BR9605387A (pt) 1-azinil-tetrazolinonas
BR9603509A (pt) Piperidinilmetiloxazolidinonas
ATE198470T1 (de) Alkenyl-benzoylguanidine
ATE240972T1 (de) Cyclopeptolide
BR9605050A (pt) Filatório
ATA119896A (de) Scheibenmähwerk
BR9503866A (pt) Autolabor
BR9501643A (pt) Helistato
FI2150U1 (fi) Serieblankett
BR9501962A (pt) Lotofone
BR7500991U (pt) Caríndio
BR9503701A (pt) Ciclo-nautica
BR9502958A (pt) Artermogeo
BR9502885A (pt) Casarreal
BR7500825U (pt) Chutegol
BR9502823A (pt) Proteserra
BR7500809U (pt) Tele-negocios
BR9502272A (pt) Livro-cartão
BR7501298U (pt) Torre-audio-visual
BR7500703U (pt) Rodopratic
BR9502123A (pt) Triamplificador
FI951066A0 (fi) Raeddningsutrustning
BR7500437U (pt) Girolight